Literature DB >> 2935411

Localisation and pharmacological characterisation of D-2 dopamine receptors in rat cerebral neocortex and cerebellum using [125I]iodosulpride.

M P Martres, N Sales, M L Bouthenet, J C Schwartz.   

Abstract

Dopamine D-2 receptors were characterised in membranes from all areas of rat cerebral cortex and from cerebellum tested, by using [125I]iodosulpride, a highly selective ligand. The IC50 values of a large variety of dopaminergic and non-dopaminergic agents against [125I]iodosulpride binding in parietal cortex or cerebellum were highly correlated with their IC50 values against [125I]iodosulpride (or [3H]domperidone) binding in striatum. Moreover in the presence of a guanylnucleotide, 5'-guanylylimidodiphosphate (GppNHp), the dopamine inhibition curves of [125I]iodosulpride binding were shifted similarly to the right in the three regions. The density of D-2 receptors in cerebellum and in most areas of the cerebral cortex represented about 1% and 2%, respectively, of their density in striatum whereas the corresponding value in frontal cortex was 4%. Labelling on autoradiographic sections was localised to superficial (I-III) and deep layers (V) of the parietal cortex and to the molecular layer of the cerebellum.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935411     DOI: 10.1016/0014-2999(85)90131-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Autoradiographic localization of dopamine D 1 and D 2 receptors in the brain of several mammalian species.

Authors:  M Camps; P H Kelly; J M Palacios
Journal:  J Neural Transm Gen Sect       Date:  1990

2.  Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride.

Authors:  M S Lidow; P S Goldman-Rakic; P Rakic; R B Innis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors.

Authors:  J P Galizzi; M Fosset; G Romey; P Laduron; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum.

Authors:  S Favrelière; L Barrier; G Durand; S Chalon; C Tallineau
Journal:  Lipids       Date:  1998-04       Impact factor: 1.880

5.  The effects of buspirone on occupancy of dopamine receptors and the rat gambling task.

Authors:  Patricia Di Ciano; Patrick Mc Cormick; Cristiana Stefan; Ernest Wong; Aaron Kim; Gary Remington; Bernard Le Foll
Journal:  Psychopharmacology (Berl)       Date:  2017-08-19       Impact factor: 4.530

6.  Antisera specific for D2 dopamine receptors.

Authors:  P L Chazot; A J Doherty; P G Strange
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

7.  Effects on resting cerebral blood flow and functional connectivity induced by metoclopramide: a perfusion MRI study in healthy volunteers.

Authors:  María A Fernández-Seara; Maite Aznárez-Sanado; Elisa Mengual; Jaione Irigoyen; Franz Heukamp; María A Pastor
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

8.  Localization of IBF as a D-2 dopamine receptor imaging agent in nonhuman primates.

Authors:  J J Billings; Y Z Guo; M P Kung; H F Kung
Journal:  Eur J Nucl Med       Date:  1993-12

9.  A simplified method for quantitation of iodine-123 iodobenzamide in human plasma: a technical note.

Authors:  Y Z Guo; M P Kung; H Cheng; N Pfeiffer; D Mozley; H F Kung
Journal:  Eur J Nucl Med       Date:  1993-05

10.  Local hippocampal methamphetamine-induced reinforcement.

Authors:  Ulises M Ricoy; Joe L Martinez
Journal:  Front Behav Neurosci       Date:  2009-11-16       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.